Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?

Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are considered one of the most effective weapons against COVID-19. During the first step of assessing vaccine immunogenicity, a mouse model is often used. In this paper, we tested the use of five experimental animals (mice, ham...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Viruses 2022-05, Vol.14 (5), p.1060
Hauptverfasser: Merkuleva, Iuliia A, Shcherbakov, Dmitry N, Borgoyakova, Mariya B, Isaeva, Anastasiya A, Nesmeyanova, Valentina S, Volkova, Natalia V, Aripov, Vazirbek S, Shanshin, Daniil V, Karpenko, Larisa I, Belenkaya, Svetlana V, Kazachinskaia, Elena I, Volosnikova, Ekaterina A, Esina, Tatiana I, Sergeev, Alexandr A, Titova, Kseniia A, Konyakhina, Yulia V, Zaykovskaya, Anna V, Pyankov, Oleg V, Kolosova, Evgeniia A, Viktorina, Olesya E, Shelemba, Arseniya A, Rudometov, Andrey P, Ilyichev, Alexander A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Currently, SARS-CoV-2 spike receptor-binding-domain (RBD)-based vaccines are considered one of the most effective weapons against COVID-19. During the first step of assessing vaccine immunogenicity, a mouse model is often used. In this paper, we tested the use of five experimental animals (mice, hamsters, rabbits, ferrets, and chickens) for RBD immunogenicity assessments. The humoral immune response was evaluated by ELISA and virus-neutralization assays. The data obtained show hamsters to be the least suitable candidates for RBD immunogenicity testing and, hence, assessing the protective efficacy of RBD-based vaccines.
ISSN:1999-4915
1999-4915
DOI:10.3390/v14051060